This inventor holds 2 USPTO granted patents. Top assignees: Chinese Academy of Sciences, Yunnan University. Active years: 2010-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2010-2016
Title: Ruirui Wang: Innovator in Pharmaceutical Chemistry
Introduction
Ruirui Wang is a notable inventor based in Kunming, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds with potential anti-HIV properties. His work has led to the filing of multiple patents, showcasing his innovative approach to addressing critical health issues.
Latest Patents
Ruirui Wang holds 2 patents that highlight his research in nitrogen-containing biphenyl compounds and concentricolide. His first patent focuses on nitrogen-containing biphenyl compounds, which includes pharmaceutical compositions and preparation methods for these compounds, as well as their anti-HIV-1 uses. The compounds are represented by a specific formula, with each substituent group defined in detail. The second patent pertains to concentricolide and its derivatives, detailing a method for their preparation, a pharmaceutical composition containing these compounds, and their application in treating and preventing HIV infections.
Career Highlights
Throughout his career, Ruirui Wang has been associated with prestigious institutions such as the Chinese Academy of Sciences and Yunnan University. His work in these organizations has allowed him to advance his research and collaborate with other experts in the field.
Collaborations
Ruirui Wang has worked alongside notable colleagues, including Yongtang Zheng and Liumeng Yang. Their collaborative efforts have contributed to the advancement of research in pharmaceutical chemistry and the development of innovative solutions for health challenges.
Conclusion
Ruirui Wang's contributions to pharmaceutical chemistry, particularly in the area of anti-HIV compounds, demonstrate his commitment to innovation and research. His patents reflect a dedication to improving health outcomes through scientific discovery.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile